Imatinib D4

• Target:

  PDGFR|||c-Kit|||SARS-CoV|||Autophagy|||Bcr-Abl

• Related Pathways:

  Autophagy|||Tyrosine Kinase/Adaptors|||Angiogenesis|||Microbiology/Virology|||Cytoskeletal Signaling

• Bioactivity:

  Imatinib D4 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.

• Smiles:

  [2H]c1c([2H])c(c([2H])c([2H])c1CN1CCN(C)CC1)C(=O)Nc1ccc(C)c(Nc2nccc(n2)-c2cccnc2)c1

• Molecular Formula:

  C29H31N7O

• Molecular Weight:

  497.63

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1134803-16-9